- The Gibco Cell Therapy Systems (CTS) product line offers the broadest platform of "clinical research–ready" solutions for your cell therapy workflow.
- CTS products provide you with the documentation and support you need to more effectively navigate the path to the clinic.
- CTS product enable you to reduce your burden in qualifying reagents during your transition from research applications to clinical applications.
Stem Cell Translational and Cell Therapy Research
We offer a collection of Cell Therapy Systems (CTS) products for cell therapy research and further manufacturing of cell-, gene- and tissue-based products. For more information about our product offerings, ordering information and customer support, access our CTS brochure.
Gibco CTS Media are manufactured according to cGMP for medical devices, 21 CFR Part 820.
Media for cell therapy
We offer cell therapy-grade media to support both feeder-dependent and feeder-free pluripotent stem cell culture including Gibco KnockOut and Essential 8 products.
Reagents for cell therapy
See below for the extended list of reagents needed for stem cell maintenance and expansion.
CTS Vitronectin (VTN-N) Recombinant Human Protein is an AOF matrix for feeder-free culture of human pluripotent stem cells designed for clinical research.
CTS CELLstart is a xeno-free stem cell substrate which is diluted with CTS DPBS w/ Ca & Mg.
CTS GlutaMAX-1 is added to the CTS KnockOut SR XenoFree complete medium, and CTS TrypLE Select is an AOF reagent used for gentle cell dissociation.
Technical and regulatory support and product documentation
View support information ›
For Research Use Only. Not for use in diagnostic procedures.